Serologic Testing of Household Contacts of Confirmed Cases of COVID-19

Status Completed

Clinical Trial Summary

SARS-CoV-2 has now crossed the 1 million number of cases and tens of thousands of deaths. It´s R0 has been calculated between 2 and 5.7 solely based on clinical symptoms but it is estimated to likely be higher. Serologic evidence of infection has not been analyzed.

Clinical Trial Description

Transverse, observational and descriptive study involving household contacts of documented patients with COVID-19 infection: contacts will be invited to participate and a blood sample will be drowned: IgM and IgG qualitative and quantitative measurements will be performed. Demographic data regarding age, comorbidities, calculated time spent before and after the patients diagnosis, isolation practices etc. ;

Study Design

Related Conditions & MeSH terms

Coronavirus Infection
Coronavirus Infections
Severe Acute Respiratory Syndrome

Clinical Trial Details

NCT number	NCT04393142
Study type	Observational [Patient Registry]
Source	Hospital Universitario Dr. Jose E. Gonzalez
Contact
Status	Completed
Phase
Start date	May 5, 2020
Completion date	February 16, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04369456` - Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients	N/A
Completed	`NCT04527471` - Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19	Phase 2
Recruiting	`NCT04410510` - P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19	Phase 2/Phase 3
Withdrawn	`NCT04383899` - Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019
Completed	`NCT04542915` - COVID-19-Related Health and Practices Among Dental Hygienists
Not yet recruiting	`NCT04400019` - Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)	Phase 2/Phase 3
Completed	`NCT04532632` - Taste and Smell Impairment in Critically Ill COVID-19 Patients
Suspended	`NCT04385771` - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	N/A
Terminated	`NCT04954014` - Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients	Phase 2
Terminated	`NCT04530448` - Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization	Phase 4
Completed	`NCT04413435` - Clinical Characteristics of Critically Ill Patients With COVID-19
Terminated	`NCT05593770` - International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response	Phase 2/Phase 3
Completed	`NCT04510493` - Canakinumab in Patients With COVID-19 and Type 2 Diabetes	Phase 3
Active, not recruiting	`NCT04587219` - The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older	Phase 2
Withdrawn	`NCT05430958` - Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers	Phase 1
Completed	`NCT04596579` - SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida
Completed	`NCT04405934` - COG-UK Project Hospital-Onset COVID-19 Infections Study	N/A
Enrolling by invitation	`NCT04484025` - SPI-1005 Treatment in Moderate COVID-19 Patients	Phase 2
Terminated	`NCT04442230` - NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)	Phase 2
Terminated	`NCT04642638` - Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure	Phase 2/Phase 3